calcium chloride + glucose, anhydrous + glucose monohydrate + magnesium chloride + sodium chloride + sodium lactate: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
calcium chloride + glucose, anhydrous + glucose monohydrate + magnesium chloride + sodium chloride + sodium lactate: clinical details
Prescribing considerations
- Select glucose concentration and osmolarity according to fluid-removal requirements, using the lowest osmolarity consistent with the clinical objective.
- Assess abdominal integrity, peritoneal function, respiratory disease, hydration, nutritional losses, glycaemic control and lactic-acidosis risk.
- Use caution with abdominal wall or intra-abdominal disease, hernia, stomas, inflammatory or ischaemic bowel disease, recent aortic grafting and severe pulmonary disease.
- Check additive compatibility and maintain strict aseptic technique.
Contraindications and cautions
- Hypersensitivity to an active substance or excipient.
- Pre-existing severe lactic acidosis.
- Uncorrectable mechanical defects preventing effective peritoneal dialysis or increasing infection risk.
- Documented loss of peritoneal function or extensive adhesions compromising function.
Monitoring
- Fluid balance, body weight, blood pressure and signs of over- or underhydration.
- Drained fluid, catheter site and symptoms of peritonitis.
- Bicarbonate, potassium, magnesium, calcium, phosphate and sodium as clinically appropriate.
- Blood glucose in diabetes; review glucose-lowering treatment when dialysis changes.
- Parathyroid hormone, lipid and haematological parameters.
- Protein, amino-acid and water-soluble-vitamin losses where clinically relevant.
Clinical pharmacology
Solutes cross the peritoneal membrane by diffusion. Glucose makes the solution hyperosmolar and drives ultrafiltration; absorbed glucose follows normal metabolic pathways. Lactate is converted towards bicarbonate, supporting acid–base correction.
Formulation and product differences
- The selected product is a clear, colourless, low-calcium, glucose-based, lactate-buffered electrolyte solution without potassium.
- Products are available with different glucose concentrations; higher concentrations create greater osmotic water removal.
- Bag configurations vary, and some include an integral drainage bag. Each bag is for single use.
calcium chloride + glucose, anhydrous + glucose monohydrate + magnesium chloride + sodium chloride + sodium lactate interactions
Peritoneal dialysis and this glucose- and lactate-containing solution can affect other treatments.
Dialysable medicines
Peritoneal dialysis may lower their blood concentrations, so clinical effect or medicine levels may require review.
Cardiac glycosides, including digoxin
Changes in potassium, calcium or magnesium can increase toxicity and abnormal-heartbeat risk; monitor electrolytes and clinical response closely.
Insulin and other glucose-lowering treatments
Glucose absorption from the dialysis fluid can alter blood-sugar control, particularly when treatment starts or changes.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.